Ondansetron 24 mg Oral Tablet
RxNorm 312084
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 312084 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ondansetron 24 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Ondansetron 24 mg Oral Tablet
(Atom ID: 12340182)
SYPrescribable
Synonym (SY):
Ondansetron 24 mg (ondansetron hydrochloride dihydrate 30 mg) Oral Tablet
(Atom ID: 3276696)
PSNPrescribable
Prescribable Name (PSN):
Ondansetron 24 mg Oral Tablet
(Atom ID: 6367628)
PTPrescribable
Designated preferred name (PT):
Ondansetron hydrochloride 24 mg oral tablet
(Atom ID: 9252355)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely ondansetron hydrochloride 24 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10315655)
Patient Education
Ondansetron
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
[Learn More]
* Please review the disclaimer below.